References
- Alfthan O. S., Rusk J. Estracyt in advanced prostatic carcinoma. Ann Chir Gynaec Fenn 1969; 58: 234
- Andersson M., Müntzing J. The effect of a long-acting estrogen on the activity and distribution of some hydrolases in the ventral prostate of intact, castrated and androgen-treated castrated, adult rats. Invest Urol 1972; 9: 401
- Flocks R. H. Carcinoma of the prostate. J Urol 1969; 101: 741
- Jänsson G. Behandling av cancer prostatae med ett kombinerat estrogen-cytostatikum. Nord Med 1969; 81: 618
- Jänsson G. Cytotoxic agents in the treatment of prostatic carcinoma. Life Sciences Monographs 1, International symposium on the treatment of carcinoma of the prostate, Berlin, G. Raspé, W. Brosig. Pergamon Press, Vieweg November 13–15, 1971; 145, 1969
- Jänsson G., Hägberg B. Treatment of advanced prostatic carcinoma with Estracyt. A preliminary report. Scan J Urol Nephrol 1971; 5: 103
- Lindberg B. Treatment of rapidly progressing prostatic carcinoma with Estracyt. J Urol 1972, in press
- Müntzing J., Nilsson T. Enzyme activity and distribution in the hyperplastic and carcinomatous human prostate gland. Scand J Urol Nephrol 1972a; 6: 107
- Müntzing J. Lipofuscin in malignant and non-malignant human prostatic tissue. Z Krebsforsch 1972b; 77: 166
- Nilsson T., Müntzing J. Estracyt in advanced prostatic carcinoma. Case report. Scan. J Urol Nephrol 1972; 6: 11
- Nilsson T. Histochemical and biochemical enzyme studies in prostatic carcinomatous tissue before and during treatment with estrogen. Scan. J Urol Nephrol 1973; 7: 14
- Weyrauch H. M., Nesbet J. D. Use of triethylene thiophosphoramide (thio-TEPA) in treatment of advanced carcinoma of prostate. J Urol 1959; 81: 185